Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model

Susan C. Fagan, Tavarekere N. Nagaraja, Joseph D. Fenstermacher, Jianqing Zheng, Maribeth H Johnson, Robert A. Knight

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The availability of reperfusion therapy for acute ischemic stroke patients has made the causes and significance of hemorrhagic transformation an area of intense interest and controversy. Ninety-two male Wistar rats underwent transient middle cerebral artery occlusion (MCAO) of between 1 and 6 h. Forty animals received 10 mg kg-1 of recombinant tissue plasminogen activator (rtPA), infused over 20 min, starting 5 min before reperfusion. At 18-24 h, the animals were sacrificed. The presence of hemorrhagic transformation (HT) on stained sections was recorded and total ischemic lesion area was quantified using image analysis software. Seventeen animals (11 with HT) were subjected to immunohistochemical analysis for detection of endothelial barrier antigen (EBA), quantified in three sections, in eight different fields per section. Chi-squared analysis and logistic regression were used to assess the contribution of rtPA and duration of occlusion to HT development. Nested, repeated measures analyses of variance were performed to assess the changes in EBA caused by ischemia and associated with HT. Fifty-nine animals developed HT that was significantly associated with occlusion duration (p < 0.0001) and ischemic lesion size (p = 0.0007). The presence of rtPA accelerated HT development. Statistically significant side-to-side differences in the presence of EBA were found in the striatum (core of the infarct) of animals with HT (p < 0.001) and without HT (p < 0.001), but only in animals with durations of occlusion of 2 h or more. Duration of occlusion is an important predictor of HT in transient MCAO in the rat and is closely associated with EBA expression.

Original languageEnglish (US)
Pages (from-to)377-382
Number of pages6
JournalNeurological Research
Volume25
Issue number4
DOIs
StatePublished - Jun 1 2003

Fingerprint

Tissue Plasminogen Activator
Stroke
Middle Cerebral Artery Infarction
Reperfusion
Therapeutics
Wistar Rats
Analysis of Variance
Software
Ischemia
Logistic Models
rat endothelial barrier antigen

Keywords

  • Endothelial barrier antigen
  • Intracerebral hemorrhage
  • Middle cerebral artery
  • Rat
  • Reperfusion
  • rtPA

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. / Fagan, Susan C.; Nagaraja, Tavarekere N.; Fenstermacher, Joseph D.; Zheng, Jianqing; Johnson, Maribeth H; Knight, Robert A.

In: Neurological Research, Vol. 25, No. 4, 01.06.2003, p. 377-382.

Research output: Contribution to journalArticle

Fagan, Susan C. ; Nagaraja, Tavarekere N. ; Fenstermacher, Joseph D. ; Zheng, Jianqing ; Johnson, Maribeth H ; Knight, Robert A. / Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. In: Neurological Research. 2003 ; Vol. 25, No. 4. pp. 377-382.
@article{334af723a49e4481a712e126cb3858d3,
title = "Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model",
abstract = "The availability of reperfusion therapy for acute ischemic stroke patients has made the causes and significance of hemorrhagic transformation an area of intense interest and controversy. Ninety-two male Wistar rats underwent transient middle cerebral artery occlusion (MCAO) of between 1 and 6 h. Forty animals received 10 mg kg-1 of recombinant tissue plasminogen activator (rtPA), infused over 20 min, starting 5 min before reperfusion. At 18-24 h, the animals were sacrificed. The presence of hemorrhagic transformation (HT) on stained sections was recorded and total ischemic lesion area was quantified using image analysis software. Seventeen animals (11 with HT) were subjected to immunohistochemical analysis for detection of endothelial barrier antigen (EBA), quantified in three sections, in eight different fields per section. Chi-squared analysis and logistic regression were used to assess the contribution of rtPA and duration of occlusion to HT development. Nested, repeated measures analyses of variance were performed to assess the changes in EBA caused by ischemia and associated with HT. Fifty-nine animals developed HT that was significantly associated with occlusion duration (p < 0.0001) and ischemic lesion size (p = 0.0007). The presence of rtPA accelerated HT development. Statistically significant side-to-side differences in the presence of EBA were found in the striatum (core of the infarct) of animals with HT (p < 0.001) and without HT (p < 0.001), but only in animals with durations of occlusion of 2 h or more. Duration of occlusion is an important predictor of HT in transient MCAO in the rat and is closely associated with EBA expression.",
keywords = "Endothelial barrier antigen, Intracerebral hemorrhage, Middle cerebral artery, Rat, Reperfusion, rtPA",
author = "Fagan, {Susan C.} and Nagaraja, {Tavarekere N.} and Fenstermacher, {Joseph D.} and Jianqing Zheng and Johnson, {Maribeth H} and Knight, {Robert A.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1179/016164103101201526",
language = "English (US)",
volume = "25",
pages = "377--382",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model

AU - Fagan, Susan C.

AU - Nagaraja, Tavarekere N.

AU - Fenstermacher, Joseph D.

AU - Zheng, Jianqing

AU - Johnson, Maribeth H

AU - Knight, Robert A.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The availability of reperfusion therapy for acute ischemic stroke patients has made the causes and significance of hemorrhagic transformation an area of intense interest and controversy. Ninety-two male Wistar rats underwent transient middle cerebral artery occlusion (MCAO) of between 1 and 6 h. Forty animals received 10 mg kg-1 of recombinant tissue plasminogen activator (rtPA), infused over 20 min, starting 5 min before reperfusion. At 18-24 h, the animals were sacrificed. The presence of hemorrhagic transformation (HT) on stained sections was recorded and total ischemic lesion area was quantified using image analysis software. Seventeen animals (11 with HT) were subjected to immunohistochemical analysis for detection of endothelial barrier antigen (EBA), quantified in three sections, in eight different fields per section. Chi-squared analysis and logistic regression were used to assess the contribution of rtPA and duration of occlusion to HT development. Nested, repeated measures analyses of variance were performed to assess the changes in EBA caused by ischemia and associated with HT. Fifty-nine animals developed HT that was significantly associated with occlusion duration (p < 0.0001) and ischemic lesion size (p = 0.0007). The presence of rtPA accelerated HT development. Statistically significant side-to-side differences in the presence of EBA were found in the striatum (core of the infarct) of animals with HT (p < 0.001) and without HT (p < 0.001), but only in animals with durations of occlusion of 2 h or more. Duration of occlusion is an important predictor of HT in transient MCAO in the rat and is closely associated with EBA expression.

AB - The availability of reperfusion therapy for acute ischemic stroke patients has made the causes and significance of hemorrhagic transformation an area of intense interest and controversy. Ninety-two male Wistar rats underwent transient middle cerebral artery occlusion (MCAO) of between 1 and 6 h. Forty animals received 10 mg kg-1 of recombinant tissue plasminogen activator (rtPA), infused over 20 min, starting 5 min before reperfusion. At 18-24 h, the animals were sacrificed. The presence of hemorrhagic transformation (HT) on stained sections was recorded and total ischemic lesion area was quantified using image analysis software. Seventeen animals (11 with HT) were subjected to immunohistochemical analysis for detection of endothelial barrier antigen (EBA), quantified in three sections, in eight different fields per section. Chi-squared analysis and logistic regression were used to assess the contribution of rtPA and duration of occlusion to HT development. Nested, repeated measures analyses of variance were performed to assess the changes in EBA caused by ischemia and associated with HT. Fifty-nine animals developed HT that was significantly associated with occlusion duration (p < 0.0001) and ischemic lesion size (p = 0.0007). The presence of rtPA accelerated HT development. Statistically significant side-to-side differences in the presence of EBA were found in the striatum (core of the infarct) of animals with HT (p < 0.001) and without HT (p < 0.001), but only in animals with durations of occlusion of 2 h or more. Duration of occlusion is an important predictor of HT in transient MCAO in the rat and is closely associated with EBA expression.

KW - Endothelial barrier antigen

KW - Intracerebral hemorrhage

KW - Middle cerebral artery

KW - Rat

KW - Reperfusion

KW - rtPA

UR - http://www.scopus.com/inward/record.url?scp=0038692041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038692041&partnerID=8YFLogxK

U2 - 10.1179/016164103101201526

DO - 10.1179/016164103101201526

M3 - Article

VL - 25

SP - 377

EP - 382

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 4

ER -